当前位置: 首页 >> 检索结果
1241. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians.
作者: Tyler Drake.;Adrienne Landsteiner.;Lisa Langsetmo.;Roderick MacDonald.;Maylen Anthony.;Caleb Kalinowski.;Kristen Ullman.;Charles J Billington.;Anjum Kaka.;Shahnaz Sultan.;Timothy J Wilt.
来源: Ann Intern Med. 2024年177卷5期618-632页
Newer diabetes medications may have beneficial effects on mortality, cardiovascular outcomes, and renal outcomes.
1242. Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in U.S. Hospitals : A Retrospective Cohort Study.
作者: Jeffrey R Strich.;Ahmed Mishuk.;Guoqing Diao.;Alexander Lawandi.;Willy Li.;Cumhur Y Demirkale.;Ahmed Babiker.;Alex Mancera.;Bruce J Swihart.;Morgan Walker.;Christina Yek.;Maniraj Neupane.;Nathaniel De Jonge.;Sarah Warner.;Sameer S Kadri.; .
来源: Ann Intern Med. 2024年177卷5期559-572页
The U.S. antibiotic market failure has threatened future innovation and supply. Understanding when and why clinicians underutilize recently approved gram-negative antibiotics might help prioritize the patient in future antibiotic development and potential market entry rewards.
1243. Cost-Effectiveness of Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review of Cost-Effectiveness Studies for the American College of Physicians.
作者: John T Schousboe.;Adrienne Landsteiner.;Tyler Drake.;Shahnaz Sultan.;Lisa Langsetmo.;Anjum Kaka.;Maylen Anthony.;Charles J Billington.;Caleb Kalinowski.;Kristen Ullman.;Timothy J Wilt.
来源: Ann Intern Med. 2024年177卷5期633-642页
In the United States, costs of antidiabetes medications exceed $327 billion.
1244. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians.
作者: Amir Qaseem.;Adam J Obley.;Tatyana Shamliyan.;Lauri A Hicks.;Curtis S Harrod.;Carolyn J Crandall.; .;Ethan M Balk.;Thomas G Cooney.;J Thomas Cross.;Nick Fitterman.;Jennifer S Lin.;Michael Maroto.;Matthew C Miller.;Paul Shekelle.;Jeffrey A Tice.;Janice E Tufte.;Itziar Etxeandia-Ikobaltzeta.;Jennifer Yost.
来源: Ann Intern Med. 2024年177卷5期658-666页
The American College of Physicians (ACP) developed this clinical guideline to update recommendations on newer pharmacologic treatments of type 2 diabetes. This clinical guideline is based on the best available evidence for effectiveness, comparative benefits and harms, consideration of patients' values and preferences, and costs.
1248. Effect of Isocaloric, Time-Restricted Eating on Body Weight in Adults With Obesity : A Randomized Controlled Trial.
作者: Nisa M Maruthur.;Scott J Pilla.;Karen White.;Beiwen Wu.;May Thu Thu Maw.;Daisy Duan.;Ruth-Alma Turkson-Ocran.;Di Zhao.;Jeanne Charleston.;Courtney M Peterson.;Ryan J Dougherty.;Jennifer A Schrack.;Lawrence J Appel.;Eliseo Guallar.;Jeanne M Clark.
来源: Ann Intern Med. 2024年177卷5期549-558页
Time-restricted eating (TRE) lowers body weight in many studies. Whether TRE induces weight loss independent of reductions in calorie intake, as seen in rodent studies, is unknown.
1250. Visual Guideline - Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Visual Clinical Guideline From the American College of Physicians.
来源: Ann Intern Med. 2024年177卷5期eM240803页
The purpose of this visual clinical guideline is to provide a visual summary of ACP's clinical guideline, "Newer Pharmacologic Treatments in Adults With Type 2 Diabetes." In addition, this visual clinical guideline features an interactive data visualization of findings associated with ACP's clinical recommendations for this topic.
1254. Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults.
作者: Swati G Patel.;Folasade P May.;Joseph C Anderson.;Carol A Burke.;Jason A Dominitz.;Seth A Gross.;Brian C Jacobson.;Aasma Shaukat.;Douglas J Robertson.
来源: Ann Intern Med. 2024年177卷4期542页 |